NutriBand Inc. Files 2025 Proxy Statement

TL;DR

NutriBand proxy filed. Vote on directors Jan 23, 2025. Check proposals.

AI Summary

NutriBand Inc. filed its definitive proxy statement on December 16, 2024, for its 2025 annual meeting of stockholders, which is scheduled for January 23, 2025. The company, incorporated in Nevada and headquartered in Orlando, Florida, operates in the orthopedic, prosthetic & surgical appliances & supplies industry. This filing outlines the proposals to be voted on by shareholders, including the election of directors and other corporate governance matters.

Why It Matters

This filing provides shareholders with crucial information about the company's governance and the proposals they will vote on at the upcoming annual meeting, impacting the direction of NutriBand Inc.

Risk Assessment

Risk Level: low — This is a routine proxy filing, providing information to shareholders about upcoming votes, and does not inherently present new financial or operational risks.

Key Numbers

• 2025 — Annual Meeting Year (The proxy statement is for the annual meeting to be held in 2025.)
• January 23 — Meeting Date (Shareholders will vote on proposals on this date.)
• December 16, 2024 — Filing Date (The definitive proxy statement was filed on this date.)

Key Players & Entities

• NutriBand Inc. (company) — Registrant
• 2025 (date) — Fiscal Year End
• January 23, 2025 (date) — Annual Meeting Date
• December 16, 2024 (date) — Filing Date
• NV (state) — State of Incorporation
• Orlando, Florida (location) — Business Address

FAQ

Key Financial Figures

• $0.001 — s of the Company’s common stock, $0.001 par value per share (the “common

Filing Documents

• ea0221125-01.htm (DEF 14A) — 1129KB
• tproxy_001.jpg (GRAPHIC) — 1202KB
• tproxy_002.jpg (GRAPHIC) — 691KB
• 0001213900-24-109109.txt ( ) — 3738KB

From the Filing

DEF 14A 1 ea0221125-01.htm PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________ SCHEDULE 14A _______________________________ Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant   Filed by a party other than the Registrant   Check the appropriate box:   Preliminary Proxy Statement   Confidential, for Use of the Commission Only (as permitted by Rule 14a -6 (e)(2))   Definitive Proxy Statement   Definitive Additional Materials   Soliciting Material under § 240.14a -12 NUTRIBAND Inc. (Name of Registrant as Specified In Its Charter) __________________________________________________________ (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply):   No fee required.   Fee paid previously with preliminary materials.   Fee computed on table below per Exchange Act Rules 14a -6 (i)(1) and 0 -11 .   NUTRIBAND INC. ANNUAL MEETING OF STOCKHOLDERS TO BE HELD JANUARY 23, 2025 Oviedo, Florida December 16, 2024 The Annual Meeting of Stockholders (the “Annual Meeting”) of Nutriband Inc., a Nevada corporation (the “Company”), will be held at 400 West Church Street, City National Hourglass Room, Orlando, FL 32801, on Thursday, January 23, 2025, at 10:00 A.M. (local time) for the following purposes: 1.       To elect seven directors to the Corporation’s Board of Directors, each to hold office for a term expiring at the next Annual Meeting of Stockholders, or until his or her successor is elected and qualified, or until his or her earlier resignation or removal; 2.       Ratification of Sadler, Gibb & Associates, LLC as the independent auditor to perform the audit of our consolidated financial statements for 2024; 3.       To hold an advisory vote to approve executive compensation; 4.       To hold an advisory vote on the frequency of future advisory votes on executive compensation; 5.       To adopt the Company’s 2024 Amended and Restated Stock Option Plan; and 6.       To transact such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof. The foregoing items of business, including the nominees for directors, are more fully described in the Proxy Statement which is attached and made a part of this Notice. The Board of Directors has fixed the close of business on December 3, 2024, as the record date for determining the stockholders entitled to notice of and to vote at the Annual Meeting and any adjournment or postponement thereof. Shares of Common Stock can be voted at the meeting only if the holder is present at the meeting in person or by valid proxy. All stockholders are cordially invited to attend the Annual Meeting in person.   By Order of the Board of Directors,     / s / Gareth Sheridan     Chief Executive Officer YOUR VOTE IS IMPORTANT It is important that as many shares as possible be represented at the annual meeting. Please date, sign, and promptly return the proxy in the enclosed envelope or you may submit your proxy via the Internet or by using the toll-free number provided on your proxy card. Your proxy may be revoked by you at any time before it has been voted.   NUTRIBAND INC. 121 South Orange Ave., Suite 1500 Orlando, Florida 32801 PROXY STATEMENT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING The Board of Directors (the “ Board ”) of Nutriband Inc. (the “ Company ”) is furnishing this proxy statement for the solicitation of proxies to be used at the Annual Shareholders Meeting (the “ Annual Meeting ”) of the Company to be held at 400 West Church Street, City National Hourglass Room, Orlando, FL 32801, on Thursday, January 23, 2025, at 10:00 A.M. (local time). The proxy materials are being mailed on or about December 17, 2024 to shareholders of record on December 3, 2024 (the “ Record Date ”). This proxy statement has been posted on the Internet and may be viewed at HTTPS: // Nutriband.com / proxy . The cost of preparing, assembling and mailing the proxy material and of reimbursing brokers, nominees and fiduciaries for the out -of -pocket and clerical expenses of transmitting copies of the proxy material to the benefici

View Full Filing

View this DEF 14A filing on SEC EDGAR